D-cycloserine added to clozapine for patients with schizophrenia. 1996

D C Goff, and G Tsai, and D S Manoach, and J Flood, and D G Darby, and J T Coyle
Psychotic Disorders Program, Massachusetts General Hospital, Boston, USA. goff@psych.mgh.harvard.edu

OBJECTIVE The effects of D-cycloserine added to clozapine were assessed and compared with previous results for D-cycloserine plus conventional neuroleptics. METHODS Ten schizophrenic outpatients receiving clozapine entered consecutive 2-week trials of placebo and D-cycloserine at 5, 15, 50, and 250 mg/day. Clinical evaluations were videotaped and scored by a rater blind to the sequence of assessments. RESULTS There was a significant dose effect of D-cycloserine on scores on the Scale for the Assessment of Negative Symptoms (SANS); the 50-mg dose produced a mean 21% increase in SANS score. The patients had significantly higher baseline serum glutamate concentrations than the patients receiving typical neuroleptics in the previous trial. Baseline glutamate level and change in glycine level significantly correlated with response of negative symptoms to 50-mg D-cycloserine. CONCLUSIONS The improvement of negative symptoms with D-cycloserine previously observed in patients receiving typical neuroleptics did not occur in patients treated with clozapine.

UI MeSH Term Description Entries
D008297 Male Males
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D011569 Psychiatric Status Rating Scales Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness. Factor Construct Rating Scales (FCRS),Katz Adjustment Scales,Lorr's Inpatient Multidimensional Psychiatric Rating Scale,Wittenborn Scales,Edinburgh Postnatal Depression Scale,Mini International Neuropsychiatric Interview
D003024 Clozapine A tricylic dibenzodiazepine, classified as an atypical antipsychotic agent. It binds several types of central nervous system receptors, and displays a unique pharmacological profile. Clozapine is a serotonin antagonist, with strong binding to 5-HT 2A/2C receptor subtype. It also displays strong affinity to several dopaminergic receptors, but shows only weak antagonism at the dopamine D2 receptor, a receptor commonly thought to modulate neuroleptic activity. Agranulocytosis is a major adverse effect associated with administration of this agent. Clozaril,Leponex
D003523 Cycloserine Antibiotic substance produced by Streptomyces garyphalus. R-4-Amino-3-isoxazolidinone,Seromycin
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

D C Goff, and G Tsai, and D S Manoach, and J Flood, and D G Darby, and J T Coyle
February 1999, Biological psychiatry,
D C Goff, and G Tsai, and D S Manoach, and J Flood, and D G Darby, and J T Coyle
July 2002, Schizophrenia research,
D C Goff, and G Tsai, and D S Manoach, and J Flood, and D G Darby, and J T Coyle
November 1999, The American journal of psychiatry,
D C Goff, and G Tsai, and D S Manoach, and J Flood, and D G Darby, and J T Coyle
March 2002, The American journal of psychiatry,
D C Goff, and G Tsai, and D S Manoach, and J Flood, and D G Darby, and J T Coyle
January 2005, Clinical neuropharmacology,
D C Goff, and G Tsai, and D S Manoach, and J Flood, and D G Darby, and J T Coyle
May 2000, The American journal of psychiatry,
D C Goff, and G Tsai, and D S Manoach, and J Flood, and D G Darby, and J T Coyle
December 1998, Biological psychiatry,
D C Goff, and G Tsai, and D S Manoach, and J Flood, and D G Darby, and J T Coyle
February 2006, Biological psychiatry,
D C Goff, and G Tsai, and D S Manoach, and J Flood, and D G Darby, and J T Coyle
February 1994, Archives of general psychiatry,
D C Goff, and G Tsai, and D S Manoach, and J Flood, and D G Darby, and J T Coyle
July 2008, International clinical psychopharmacology,
Copied contents to your clipboard!